Go Back

Simon Nadal

CY Cergy Paris University

Contact

Attach file 8Mb max size

Checkmark Done Circle

Message sent succesfully

About
First Name
Simon
Last Name
Nadal
University
CY Cergy Paris University
Current position
Group Leader
Email
simon.nadal@cyu.fr
Personal webpage
www.nadal-lab.eu
Researcher Identification
ORCID
ORCID
0000-0002-0748-0284
Keywords
Multiple Myeloma ; Chemical Proteomics ; Minimal Residual Disease (MRD) monitoring by Mass Spectrometry ; Chemical Biology ; Epigenetics
Health related-scientific domains
Applied Medical Technologies, Diagnostics, Therapies
Life Sciences related to Health
Research expertise/competencies
Multiple Myeloma, Proteomics, Mass Spectrometry, Chemical Biology, Protein Chemistry, Synthetic proteins, Post-translational mutagenesis, Histone Post-translational modifications
Faculty / Institute / Department
Faculty of Sciences & Technology / Department of Chemistry
Research center/group
BioCIS : Biomolecules : Design, Isolation, Synthesis
Research center/group website
Available major infrastructure
- Fully equipped organic synthesis lab - Fully equipped peptide synthesis platform (PeptLab) - Fully equipped BSL-1 protein chemistry lab (recombinant protein production and purification, post-translational mutagenesis) - BSL-2 Cell culture lab (human myeloma cell lines) - Mass spectrometry: UPLC-Q-ToF (Waters), partnership access to nUPLC-ESI-Orbitrap (Thermo Orbitrap Eclipse)
Collaboration-based research services
- (Semi-) Synthesis of proteins carrying chemically-defined post-translational modifications (example histone mono/di/tri-methylation, phosphorylation, acetylation, GlcNAc glycosylation etc.) through post-translation chemical mutagenesis
Contractual research services
- The unit offers Peptide synthesis services via the PeptLab platform
Website describing services
Topics for collaboration
- Minimal residual disease monitoring in multiple myeloma - Antigenic stimulation as growth stimulus in multiple myeloma - Epigenetic changes in multiple myeloma - Histone post-translational modifications in multiple myeloma